Non-alcoholic Fatty Liver Disease and Steatohepatitis in HIV Disease
Elizabeth C. Verna, MD
Assistant Professor of Medicine
Director of Clinical Research, Center for Liver Disease and Transplantation
Columbia University, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Dr. Elizabeth Verna earned her BA in Biology at the University of Virginia prior to attending the Columbia University College of Physicians and Surgeons for medical school. She completed her Internal Medicine residency at Columbia and then served as a Chief Resident before remaining at Columbia for fellowships. While in fellowship, she completed a Masters in Biostatistics at the Columbia University Mailman School of Public Health. Dr. Verna is now an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University. She is board certified in Internal Medicine, Gastroenterology as well as Liver Transplantation. She has a clinical practice that includes patients with all forms of chronic liver disease and liver transplant recipients, and has an active research program with grant support for studies in the areas of hepatitis C, hepatic fibrosis, liver transplant and the intestinal microbiome. She is also the Director of Clinical Research for the Columbia University Transplant Initiative and the Program Director for the Transplant Hepatology Fellowship.
At the completion of this educational session, learners will:
- Recognize risk factors for non-alcoholic fatty liver disease (NAFLD) in their patients with HIV.
- Be more familiar with the diagnostic testing available to identify and stage patients with NAFLD and HIV.
- Understand the natural history of NAFLD in patients with HIV and the potential impact of NAFLD and liver disease on mortality in this population.
- Appreciate that there are many treatments for NAFLD currently in clinical trials and that treatment to alter the natural history of NAFLD in patients with HIV may soon be available.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Video Channel at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
